Similar articles

• [Controlled clinical study of the blood pressure lowering effect of a rauwolfia-saluretic combination, with and without addition of an adrenolytic agent].

  Esch I, Wohlzogen FX, Scheiber V. Esch I, et al. Wien Z Inn Med. 1971;52(5):265-71. Wien Z Inn Med. 1971. PMID: 4999322 Clinical Trial. German. No abstract available.
• [The antihypertensive combination DCR (dihydroergocristine, clopamide, reserpine)].

  Hummel R, Flückiger E. Hummel R, et al. Med Klin. 1968 Apr 5;63(14):536-40. Med Klin. 1968. PMID: 4972528 German. No abstract available.
• [Glomerular filtrate, renal plasma flow, and sodium excretion in hypertensive patients before and following antihypertensive treatment with combination preparations].

  Habermann W, Stumpe KO, Krück F. Habermann W, et al. Med Klin. 1972 Oct 20;67(42):1363-7. Med Klin. 1972. PMID: 4629612 German. No abstract available.
• Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.

  Kondrack R, Mohiuddin S. Kondrack R, et al. Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1125-34. doi: 10.1517/17425250903136730. Expert Opin Drug Metab Toxicol. 2009. PMID: 19689218 Review.
• Telmisartan/hydrochlorothiazide: a new fixed dose combination.

  Maillard M, Burnier M. Maillard M, et al. Expert Rev Cardiovasc Ther. 2005 May;3(3):375-86. doi: 10.1586/14779072.3.3.375. Expert Rev Cardiovasc Ther. 2005. PMID: 15889965 Review.